Sep 22, 09:09
AnnouncementsInd-Swift Laboratories: Outcome of board meeting
100% of moneycontrol users recommend buying Ind-Swift Labs.
What's your call on Ind-Swift Labs today?
Read 5 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3212.20||-0.19||3240.00||2420.00||54,724.91|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
RS Software (India) Recommended on Aug 12th 2014
Recommended price 430.00 | Peak from reco 829.30 92.86%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Ind-Swift Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 162.42 crore.The company has reported a standalone sales of Rs 184.11 crore and a Net Loss of Rs -17.12 crore for the quarter ended Jun 2014.
The company management includes S R Mehta - Chairman, N R Munjal - Vice Chairman & Mng.Director, Himanshu Jain - Joint Managing Director, Rishav Mehta - Executive Director, V R Mehta - Director, G Munjal - Director, K M S Nambiar - Director, T S Bhattacharya - Director, J K Kakkar - Director, Pradeep Kumar - Director, Satyendra Vikram Singh - Nominee Director, Vinay Kumar Arora - Independent Director.
It is listed on the BSE with a BSE Code of 532305 and the NSE with an NSE Code of INDSWFTLAB.
Its Registered office is at SCO 850, Shivalik Enclave,,NAC, Manimajra Chandigarh,Chandigarh - 160101.
Their Registrars are Alankit Assignment Ltd.